Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease-Oxidative Stress and Inflammation Relevance

Medicina (Kaunas). 2023 Sep 7;59(9):1614. doi: 10.3390/medicina59091614.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. Its incidence is progressively rising and it is possibly becoming a worldwide epidemic. NAFLD encompasses a spectrum of diseases accounting for the chronic accumulation of fat within the hepatocytes due to various causes, excluding excessive alcohol consumption. In this study, we aimed to focus on finding evidence regarding the implications of oxidative stress and inflammatory processes that form the multifaceted pathophysiological tableau in relation to thrombotic events that co-occur in NAFLD and associated chronic liver diseases. Recent evidence on the pathophysiology of NAFLD suggests that a complex pattern of multidirectional components, such as prooxidative, proinflammatory, and prothrombotic components, better explains the multiple factors that promote the mechanisms underlying the fatty acid excess and subsequent processes. As there is extensive evidence on the multi-component nature of NAFLD pathophysiology, further studies could address the complex interactions that underlie the development and progression of the disease. Therefore, this study aimed to describe possible pathophysiological mechanisms connecting the molecular impairments with the various clinical manifestations, focusing especially on the interactions among oxidative stress, inflammation, and coagulation dysfunctions. Thus, we described the possible bidirectional modulation among coagulation homeostasis, oxidative stress, and inflammation that occurs in the various stages of NAFLD.

Keywords: adipokines; endoplasmic reticulum; foamy cells; hepatic steatosis; hypercoagulability; lipid peroxidation; macrophages; mitochondria; reactive oxygen species; steatohepatitis; thrombosis.

Publication types

  • Review

MeSH terms

  • Blood Coagulation
  • Blood Coagulation Disorders*
  • Humans
  • Inflammation
  • Non-alcoholic Fatty Liver Disease* / complications
  • Oxidative Stress
  • Skin Diseases*

Grants and funding

This research received no external funding.